Medtech Acquisition Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedTech Acquisition (OTCMKTS:MTACU) Trading 19 5% Higher

MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) shares traded up 19.5% during mid-day trading on Monday . The stock traded as high as $11.35 and last traded at $11.35. 1,900 shares traded hands during trading, an increase of 225% from the average session volume of 585 shares. The stock had previously closed at $9.50. […]

United statesMedtech acquisition coMedtech acquisition corporationMedtech acquisitionGet free reportTech acquisition corporationMedtech acquisition dailyOtcmkts mtacuFinancial service

MedTech Acquisition (OTCMKTS:MTACU) Trading Up 19 5%

MedTech Acquisition (OTCMKTS:MTACU) Trading Up 19 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMedtech acquisition corporationMedtech acquisition company profileMedtech acquisition coMedtech acquisitionGet free reportTech acquisition corporationMedtech acquisition daily

Reviewing Castle Biosciences (NASDAQ:CSTL) and MedTech Acquisition (NASDAQ:MTAC)

MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Profitability This table compares MedTech Acquisition and […]

United statesCastle biosciencesDecisiondx diffdxCastle bioscienceCastle biosciences incMedtech acquisition corporationMedtech acquisition sponsorMedtech acquisitionGet free reportTech acquisitionGiven castle bioscienceTech acquisition corporationDecisiondx diffdx melanomaPath melanomaMedtech acquisition dailyNasdaq mtac

MedTech Acquisition Co (NASDAQ:MTACW) Short Interest Update

MedTech Acquisition Co. (NASDAQ:MTACW – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 4,700 shares, an increase of 38.2% from the June 15th total of 3,400 shares. Based on an average daily volume of 9,000 shares, the short-interest ratio […]

Polar asset management partners incMedtech acquisition coExchange commissionMedtech acquisitionGet free reportTech acquisitionAsset management partnersFree reportMedtech acquisition dailyNasdaq mtacw

Financial Contrast: MedTech Acquisition (NASDAQ:MTAC) versus Castle Biosciences (NASDAQ:CSTL)

MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of […]

United statesDecisiondx diffdxCastle bioscienceCastle biosciencesMedtech acquisition sponsorMedtech acquisition corporationCastle biosciences incMedtech acquisitionGet free reportGiven castle bioscienceTech acquisitionTech acquisition corporationDecisiondx diffdx melanomaPath melanomaMedtech acquisition dailyNasdaq mtac